NewGenIVF Group has finalized a $10 million Pre-A funding round for K25.ai, a prediction market platform, securing a 10% stake. The Nasdaq-listed company invested an additional $4 million, bringing its total investment to $10 million at a $100 million valuation. NewGenIVF also obtained exclusive agency rights for K25.ai in the Asia-Pacific region. K25.ai, an AI-native livestreaming and prediction market platform, is targeting the Asia-Pacific market and is in the process of obtaining regulatory approvals. The company plans to use the new funds for product launch, regulatory licensing, and regional expansion. This investment follows earlier contributions of $2 million in May and $4 million in early June 2026, and marks the beginning of K25.ai's Series A funding round.